Harold H. Shlevin
CIK: 0001557082
Harold H. Shlevin's purchase track record
Harold H. Shlevin has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/30/2024 | GALT | $8K | +10.9% | +91.8% | +5.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| GALT | ▲ Buy | Option Exercise | 22,268 | $27K | 6/29/2026 | View on chart |
| GALT | ▼ Sell | Open Market | 22,268 | $112K | 6/29/2026 | View on chart |
| GALT | ▼ Sell | Open Market | 7,732 | $39K | 6/26/2026 | View on chart |
| GALT | ▲ Buy | Option Exercise | 7,732 | $10K | 6/26/2026 | View on chart |
| GALT | ▲ Buy | Option Exercise | 20,000 | $40K | 12/17/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 19,793 | $139K | 12/17/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 4,706 | $33K | 12/17/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 8,417 | $35K | 12/15/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 8,417 | $53K | 12/15/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 19,793 | $82K | 12/12/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 19,793 | $124K | 12/12/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 16,790 | $70K | 12/9/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 16,790 | $105K | 12/9/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 25,000 | $149K | 12/8/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 35,000 | $74K | 12/8/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 35,000 | $211K | 12/8/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 20,000 | $120K | 12/8/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 35,000 | $100K | 12/8/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 35,000 | $208K | 12/8/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 20,000 | $42K | 12/8/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 20,000 | $119K | 12/8/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 20,000 | $40K | 12/8/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 20,000 | $119K | 12/8/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 25,000 | $43K | 12/8/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 20,000 | $22K | 12/8/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 4,000 | $24K | 12/8/2025 | View on chart |
| GALT | ▲ Buy | Open Market | 6,500 | $8K | 12/30/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Galectin Clears Balance Sheet with $105M Debt Conversion
Galectin Therapeutics announced that a $105 million debt conversion has removed its outstanding debt, improving its balance sheet. The company still needs to secure a Phase 3 partnership to move its lead product forward. The move may reduce financial risk but the next milestone remains critical for the company's progress.
Galectin Clears Balance Sheet with $105M Debt Conversion. Galectin Therapeutics announced that a $105 million debt conversion has removed its outstanding debt, improving its balance sheet. The company still needs to secure a Phase 3 partnership to move its lead product forward. The move may reduce financial risk but the next milestone remains critical for the company's progress.